Bozza’s research team activities involve clinical and translational research on severe emerging and re-emerging infectious diseases. The investigations have focused on the long-term outcomes of severe infections, including the neuro-cognitive consequences of sepsis, malaria, and HIV. In recent years, he also worked in the consolidation of new collaborative initiatives of clinical research in Brazil and Latin America to fill the gaps of knowledge regarding the management of critically ill patients in developing countries and the development of large collaborative studies in these settings.
COVID-19 hospital admissions: Brazil’s first and second waves compared. Bastos LS, Ranzani OT, Souza TML, Hamacher S, Bozza FA. Lancet Respir Med. 2021 Aug;9(8):e82-e83.
Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Kurtz P, Bastos LSL, Dantas LF, Zampieri FG, Soares M, Hamacher S, Salluh JIF, Bozza FA. Intensive Care Med. 2021 May;47(5):538-548.
App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning. Dantas LF, Peres IT, Bastos LSL, Marchesi JF, de Souza GFG, Gelli JGM, Baião FA, Maçaira P, Hamacher S, Bozza FA. PLoS One. 2021 Mar25;16(3):e0248920.
Sociodemographic factors associated with COVID-19 in-hospital mortality in Brazil. Peres IT, Bastos LSL, Gelli JGM, Marchesi JF, Dantas LF, Antunes BBP, Maçaira PM, Baião FA, Hamacher S, Bozza FA. Public Health. 2021 Mar;192:15-20.
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S, Bozza FA. Lancet Respir Med. 2021 Apr;9(4):407-418.